P Peptide Calculator
Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
PEG-IGF-1 and Acetic Acid Mix

PEG-IGF-1 Reconstitution Calculator

Reviewed by · Pharmacist and Scientific Reviewer

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

⚠ Use acetic acid — not bacteriostatic water PEG-IGF-1 is insoluble or unstable in standard BAC water. Manufacturer protocols require reconstitution in dilute acetic acid (0.1%) — or, for IGF-1 variants, 50 mM acetic acid. Volumes shown below refer to acetic acid, not water.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example PEG-IGF-1 Titration Schedule

ParameterDetails
MoleculeRO5046013 (Roche)
Half-life140–200 h (Phase 1)
Trial statusPhase 1 only (n=62, 2017)
Key findingNo hypoglycemia (PEGylation blunts insulin-mimetic spike)

A real but development-halted compound. The '0.3–8 mg' listed range has no protocol behind it — Phase 1 used single ascending doses, and no human efficacy data exist. Vendor vials are not the Roche molecule.

Possible vial strengths:

What Is It?

PEG-IGF-1

Pegylated IGF-1 with extended half-life.

Acetic Acid (0.1%)

A dilute solution of acetic acid (typically 0.1% for most peptides, or 50 mM for IGF-1 variants) used to reconstitute peptides that are insoluble or unstable in standard bacteriostatic water. PEG-IGF-1 requires an acidic carrier to dissolve fully and remain stable — plain BAC water will not work and may damage the peptide.

How To Mix PEG-IGF-1

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw Acetic Acid

Draw the selected amount of 0.1% acetic acid.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

PEG-IGF-1 Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

Yes, the same concentration math can be used when the inputs are known: compound amount, liquid volume, and target concentration. The calculator does not decide whether IGF-1 LR3 and PEG MGF belong together; it only converts vial amount and solution volume into mg/mL or mcg/mL values for research planning
Because “cycle” usually implies personal-use timing or dosing, which a reconstitution calculator should not provide. A safer calculator FAQ can explain how separate vial strengths and liquid volumes change concentration, without giving protocols, schedules, or use instructions.
In calculator terms, “PEG IGF-1” should be treated as a label that still needs exact vial information before any math is useful. The key inputs are the measured amount of material in the vial and the final liquid volume, because those determine the working concentration.
No, the basic concentration formula does not change: amount divided by final volume. What changes is the compound identity, labeling, molecular form, and research context, so each vial should be calculated separately instead of assuming the same concentration setup applies to both.
No. A reconstitution calculator can only show concentration math, such as how much compound is present per mL after liquid is added. It should not provide injury-repair dosing, medical advice, injection guidance, or human-use protocols.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

More Growth Hormone calculators

CJC-1295 DAC ModGRF 1-29 (CJC-1295 No DAC) Ipamorelin GHRP-2 GHRP-6 GHRH Hexarelin Sermorelin

References

  1. Thienpont L, et al. First-in-man study of RO5046013. J Clin Endocrinol Metab. 2017.

About the author

· Pharmacist and Scientific Reviewer

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides